3139 results for «315»
3139 results
Complications of mitral valve interventions
19 Nov 2023 – From PCR London Valves 2023
Learn more about the complexities of mitral valve interventions with this selection of cases: witness the challenges posed by clip embolisation during Mitral TEER, delve into the scenario of SAM following TMVI leading to left ventricular outflow tract obstruction, explore the closure of an iatrogenic ASD...
TAVI in bicuspid anatomy - Part 1
19 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Tricuspid TEER - Part 1
19 Nov 2023 – From PCR London Valves 2023
Gain insights into Tricuspid Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the congestion patterns observed in severe tricuspid regurgitation and gain a deeper understanding of transcatheter treatment modalities, delve into the baseline characteristics of the Tri.Fr randomized trial on treating tricuspid regurgitation, witness the application...
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
TAVI in cardiogenic shock
19 Nov 2023 – From PCR London Valves 2023
Because TAVI implantation, a routine procedure, is not always a breeze, look at a number of challenging cases, including a case of aortic stenosis complicated by cardiogenic shock, an emergency valve-in-valve TAVI, or a TAVI for left ventricular assist device.
TAVI - Alternative access - Part 2
20 Nov 2023 – From PCR London Valves 2023
Delve into alternative access strategies in TAVI with this session: navigate through cases featuring complex aortic anatomy in TAVI patients, witness the innovative use of intravascular lithotripsy of the abdominal aorta to facilitate transcaval valve-in-valve TAVR and explore the technique of transseptal TAVR.
TAVI - complications
21 Nov 2023 – From PCR London Valves 2023
Because TAVI is not without risk, learn about bailout endovascular techniques to counter transcatheter aortic valve LV dislocation, analyze the cost of infectious complications caused by TAVR compared with SAVR, and discover how imaging can predict aortic root rupture or conduction abnormalities, among others.
New devices for tricuspid valve intervention
20 Nov 2023 – From PCR London Valves 2023
Join this session for a quick overview of groundbreaking devices shaping tricuspid valve interventions: witness the first-in-man experience with a cross-caval device designed for the treatment of tricuspid regurgitation, navigate through a challenging case involving a patient with massive tricuspid regurgitation and a permanent pacemaker lead and...
Coronary imaging in the structural cathlab
21 Nov 2023 – From PCR London Valves 2023
If you still have any doubts, take a look at the presentations in this PCR LV 2023 session to be convinced of the importance of imaging, particularly IVUS, pre-, during and post-TAVI! It helps to prevent coronary artery occlusions, manage post-TAVR complications and guide rotablation, to name...
Mitral TEER - Part 1
20 Nov 2023 – From PCR London Valves 2023
Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.
Interventions for multiple valve disease
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover innovative strategies for managing multiple valve diseases: witness the strategic staging of treatments using two distinct devices for mitigating mitral and tricuspid regurgitation, navigate the challenges encountered in a patient presenting with severe mitral and tricuspid regurgitation and unable for edge-to-edge procedures,...
Complex tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Consult this session to discover a selection of abstracts regarding tricuspid valve procedures: explore the complexities of long-term right heart remodeling after transcatheter tricuspid annuloplasty, witness the journey from pre-clinical studies to the first-in-man experience with MonarQ tricuspid valve replacement, delve into Tripair, an innovative transcatheter spacer...
Alternative structural interventions
21 Nov 2023 – From PCR London Valves 2023
Join us in this session as we delve into unconventional structural interventions through two distinct studies: one focusing on evaluating the quality of trials investigating percutaneous PFO closure as a potential treatment for migraines, the other exploring the novel landscape of percutaneous procedures extending beyond the...
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
TAVI - Commissural alignment
20 Nov 2023 – From PCR London Valves 2023
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
